Back to Journals » ClinicoEconomics and Outcomes Research » Volume 10
Original Research
Cost-effectiveness analysis of ribociclib versus palbociclib in the first-line treatment of HR+/HER2– advanced or metastatic breast cancer in Spain
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
13,893 | Dovepress* | 10,487+ | 1,615 | 12,102 | |
PubMed Central* | 3,406 | 768 | 4,174 | ||
Totals | 13,893 | 2,383 | 16,276 | ||
*Since 14 November 2018 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed Central and Google Scholar